• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

rT2期复发性鼻咽癌患者内镜挽救性手术的临床预后分析

[Analysis of clinical prognosis of endoscopic salvage surgery in patients with rT2 recurrent nasopharyngeal carcinoma].

作者信息

Song X L, Li W P, Yang J Y, Zhang H K, Wang H, Xue K, Liu Q, Sun X C, Yu H M, Wang D H

机构信息

Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China Research Units of New Technologies of Endoscopic Surgery in Skull Base Tumor, Chinese Academy of Medical Sciences (2018RU003), Shanghai 200031, China.

出版信息

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Dec 7;57(12):1442-1449. doi: 10.3760/cma.j.cn115330-20210930-00646.

DOI:10.3760/cma.j.cn115330-20210930-00646
PMID:36707948
Abstract

To investigate the feasibility of endoscopic salvage surgery for patients with rT2 recurrent nasopharyngeal carcinoma (rNPC) and to analyze their prognostic factors. The clinical data of 33 patients with rT2 rNPC who underwent endoscopic extended nasopharyngectomy in Eye & ENT Hospital Affiliated to Fudan University from January 2015 to July 2020 were analyzed, including 29 males (87.9%) and 4 females (12.1%), aging (51.7±10.6) years. The clinicopathological characteristics of these patients were recorded and analyzed, in terms of gender, sex, alcohol and cigarette use, interval between primary treatment to recurrence, adjuvant therapy, lymph node metastasis, internal carotid artery (ICA) invasion, necrosis, margin and reconstruction materials. Kaplan Meier analysis was used to plot the overall survival rate and progression free survival rate curve, Log-rank test was used to analyze the prognostic factors among patients, and multivariate Cox proportional hazards regression was used to determine the independent risk factors of tumor progression free survival. Among 33 patients with rT2 rNPC, the recurrence interval of 24 patients with rNPC after primary radiotherapy was more than 2 years. A total of 25 patients received primary radiotherapy and adjuvant chemotherapy at the same time. There were 6 cases with cervical lymph node metastasis, 12 cases with ICA invasion, 8 cases with positive surgical margin, 7 cases underwent ICA embolization before operation. A total of 18 cases underwent pedicled tissue flap repairment after operation, including 12 pedicled nasal septal mucosa flaps and 6 temporalis muscle flaps. The median follow-up time was 15 months. Five patients died because of disease progression (in 2 cases), post surgical ICA hemorrhage (in 1 case), liver metastasis (in 1 case) and dysphagia (in 1 case). The 1-year, 2-year and 3-year overall survival rates of all patients were 93.9%, 81.8% and 81.8%, respectively. The 1-year, 2-year and 3-year progression free survival rates were 74.7%, 59.7% and 40.9%, respectively. Log-rank statistical analysis showed that the positive surgical margin (=0.060) and recurrence interval (=0.151) were possibly related to the prognosis of rT2 rNPC. Multivariate Cox regression analysis showed that the positive surgical margin was an independent risk factor for patients with rT2 rNPC (=0.034). Nasopharynx hemorrhage occurred in 4 patients, skull base bone necrosis occurred in 2 patients, trismus occurred in 3 patients, and no obvious brain complications occurred in 7 patients with ICA embolization. Endoscopic salvage surgery for rT2 rNPC is a safe and effective surgical option, but the long-term effect still needs long-term follow-up in bulk cases.

摘要

探讨内镜挽救性手术治疗复发T2期鼻咽癌(rNPC)患者的可行性,并分析其预后因素。分析2015年1月至2020年7月在复旦大学附属眼耳鼻喉科医院接受内镜扩大鼻咽癌切除术的33例rT2期rNPC患者的临床资料,其中男性29例(87.9%),女性4例(12.1%),年龄(51.7±10.6)岁。记录并分析这些患者的临床病理特征,包括性别、烟酒使用情况、初次治疗至复发的间隔时间、辅助治疗、淋巴结转移、颈内动脉(ICA)侵犯、坏死、切缘及重建材料。采用Kaplan-Meier分析绘制总生存率和无进展生存率曲线,采用Log-rank检验分析患者的预后因素,采用多因素Cox比例风险回归分析确定肿瘤无进展生存的独立危险因素。33例rT2期rNPC患者中,24例rNPC患者初次放疗后的复发间隔超过2年。共有25例患者同时接受了初次放疗和辅助化疗。有6例发生颈部淋巴结转移,12例发生ICA侵犯,8例手术切缘阳性,7例术前接受了ICA栓塞。共有18例患者术后接受了带蒂组织瓣修复,其中带蒂鼻中隔黏膜瓣12例,颞肌瓣6例。中位随访时间为15个月。5例患者因疾病进展(2例)、术后ICA出血(1例)、肝转移(1例)和吞咽困难(1例)死亡。所有患者的1年、2年和3年总生存率分别为93.9%、81.8%和81.8%。1年、2年和3年无进展生存率分别为74.7%、59.7%和40.9%。Log-rank统计分析显示,手术切缘阳性(=0.060)和复发间隔(=0.151)可能与rT2期rNPC的预后有关。多因素Cox回归分析显示,手术切缘阳性是rT2期rNPC患者的独立危险因素(=0.034)。4例患者发生鼻咽出血,2例患者发生颅底骨坏死,3例患者发生张口受限,7例接受ICA栓塞的患者未出现明显脑部并发症。内镜挽救性手术治疗rT2期rNPC是一种安全有效的手术选择,但长期效果仍需大量病例的长期随访。

相似文献

1
[Analysis of clinical prognosis of endoscopic salvage surgery in patients with rT2 recurrent nasopharyngeal carcinoma].rT2期复发性鼻咽癌患者内镜挽救性手术的临床预后分析
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Dec 7;57(12):1442-1449. doi: 10.3760/cma.j.cn115330-20210930-00646.
2
[Internal carotid artery embolization in endoscopic salvage surgery for recurrent nasopharyngeal carcinoma: a single-center retrospective study].[内镜挽救手术治疗复发性鼻咽癌的颈内动脉栓塞:单中心回顾性研究]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Nov 7;57(11):1294-1303. doi: 10.3760/cma.j.cn115330-20220425-00221.
3
5-year outcomes of salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma.复发性鼻咽癌挽救性鼻内镜下鼻咽癌切除术的5年疗效
J Otolaryngol Head Neck Surg. 2021 Feb 17;50(1):12. doi: 10.1186/s40463-020-00482-x.
4
Innovative application of internal carotid artery embolization in salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: A case-matched comparison.颈内动脉栓塞术在复发性鼻咽癌挽救性鼻内镜下鼻咽癌切除术中的创新应用:病例对照比较
Int Forum Allergy Rhinol. 2022 Jun;12(6):838-848. doi: 10.1002/alr.22927. Epub 2021 Dec 7.
5
[Observation on clinical efficacy and prognosis analysis of endoscopic surgery treatment for rT1-rT2 recurrent nasopharyngeal carcinoma].内镜手术治疗rT1-rT2复发性鼻咽癌的临床疗效观察及预后分析
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Apr;33(4):337-341. doi: 10.13201/j.issn.1001-1781.2019.04.012.
6
Endoscopic Nasopharyngectomy Combined With Internal Carotid Artery Pretreatment for Recurrent Nasopharyngeal Carcinoma.内镜下鼻咽癌切除术联合颈内动脉预处理治疗复发性鼻咽癌
Otolaryngol Head Neck Surg. 2022 Mar;166(3):490-497. doi: 10.1177/01945998211011076. Epub 2021 Jun 29.
7
[Analysis of clinical efficacy and the quality of life after endoscopic nasopharyngectomy for residual or recurrent nasopharyngeal carcinoma].[内镜下鼻咽切除术治疗残留或复发性鼻咽癌的临床疗效及生活质量分析]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Nov;50(11):896-903.
8
[Endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 71 patients and analysis of the prognostic factors].[复发性鼻咽癌的鼻内镜下鼻咽切除术:71例患者回顾及预后因素分析]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Nov;50(11):890-5.
9
Five-year Survival Data on the Role of Endoscopic Endonasal Nasopharyngectomy in Advanced Recurrent rT3 and rT4 Nasopharyngeal Carcinoma.内镜下鼻内鼻咽切除术在晚期复发性rT3和rT4鼻咽癌中作用的五年生存数据
Ann Otol Rhinol Laryngol. 2020 Mar;129(3):287-293. doi: 10.1177/0003489419887410. Epub 2019 Nov 8.
10
Outcomes of recurrent nasopharyngeal carcinoma patients treated with endoscopic nasopharyngectomy: a meta-analysis.内镜下鼻咽切除术治疗复发性鼻咽癌患者的结局:一项荟萃分析。
Int Forum Allergy Rhinol. 2020 Aug;10(8):1001-1011. doi: 10.1002/alr.22552. Epub 2020 May 25.